アレルギー性鼻炎(Allergic Rhinitis)の治療薬パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Allergic Rhinitis Overview 9
Therapeutics Development 10
Pipeline Products for Allergic Rhinitis – Overview 10
Pipeline Products for Allergic Rhinitis – Comparative Analysis 11
Allergic Rhinitis – Therapeutics under Development by Companies 12
Allergic Rhinitis – Therapeutics under Investigation by Universities/Institutes 16
Allergic Rhinitis – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Allergic Rhinitis – Products under Development by Companies 20
Allergic Rhinitis – Products under Investigation by Universities/Institutes 26
Allergic Rhinitis – Companies Involved in Therapeutics Development 27
3M Drug Delivery Systems 27
Adamis Pharmaceuticals Corporation 28
ALK-Abello A/S 29
AnaptysBio, Inc. 30
Axikin Pharmaceuticals, Inc. 31
BioTech Tools s.a. 32
ELORAC, Inc. 33
FAES Farma SA 34
Fountain Biopharma Inc. 35
GenMont Biotech Inc. 36
GlaxoSmithKline plc 37
Glenmark Pharmaceuticals Ltd. 38
GlycoMar Limited 39
HAL Allergy BV 40
Hanmi Pharmaceuticals, Co. Ltd. 41
Hisamitsu Pharmaceutical Co., Inc. 42
Johnson & Johnson 43
Laboratorios LETI S.L. 44
Ligand Pharmaceuticals, Inc. 45
Marinomed Biotechnologie GmbH 46
Merck & Co., Inc. 47
Mitsubishi Tanabe Pharma Corporation 48
Nektar Therapeutics 49
NeoPharm Co., Ltd. 50
Novartis AG 51
Nuvo Research Inc. 52
Ono Pharmaceutical Co., Ltd. 53
Oxagen Limited 54
Panmira Pharmaceuticals, LLC. 55
Pfizer Inc. 56
Protectimmun GmbH 57
Revance Therapeutics, Inc. 58
Rottapharm SpA 59
Shionogi & Co., Ltd. 60
Stallergenes S.A. 61
Sun Pharma Advanced Research Company Ltd. 62
Trimel BioPharma SRL 63
VentiRx Pharmaceuticals, Inc. 64
Xencor, Inc. 65
Ziarco Pharma Ltd 66
Allergic Rhinitis – Therapeutics Assessment 67
Assessment by Monotherapy Products 67
Assessment by Combination Products 68
Assessment by Target 69
Assessment by Mechanism of Action 71
Assessment by Route of Administration 73
Assessment by Molecule Type 75
Drug Profiles 77
(azelastine hydrochloride + mometasone furoate) – Drug Profile 77
(fluticasone furoate + levocabastine hydrochloride) – Drug Profile 78
(GSP 301-1 NS + GSP 301-2 NS) – Drug Profile 79
(montelukast sodium + levocetirizine dihydrochloride) – Drug Profile 80
854-A – Drug Profile 81
Allergen for Birch Pollen Induced Allergic Rhinitis and Rhinoconjunctivitis – Drug Profile 82
Allergen for House Dust Mites Induced Allergic Rhinitis and Rhinoconjunctivitis – Drug Profile 83
Allergen for Pollen Grass Allergy Induced Allergic Rhinitis and Rhinoconjunctivitis – Drug Profile 85
allergenic pollen extract of timothy – Drug Profile 86
AM-211 – Drug Profile 87
AM-461 – Drug Profile 89
ANB-020 – Drug Profile 91
andolast – Drug Profile 92
APC-3000 – Drug Profile 93
Arabinogalactan – Drug Profile 94
AVANZ Olive Immunotherapy for Allergic Rhinitis – Drug Profile 95
Avanz Phleum Pratense – Drug Profile 96
bepotastine besylate – Drug Profile 97
bilastine – Drug Profile 99
budesonide – Drug Profile 100
C-525 – Drug Profile 101
CBP-174 – Drug Profile 102
cidoxepin hydrochloride – Drug Profile 103
Depigoid Birch – Drug Profile 104
Dermatophagoides Pteronyssinus Allergen Extract – Drug Profile 105
desloratadine – Drug Profile 106
Drug for Japanese Cedar Pollen Allergy – Drug Profile 107
esketamine – Drug Profile 108
FB-825 – Drug Profile 110
fevipiprant – Drug Profile 111
fluticasone furoate – Drug Profile 113
GLY-079 – Drug Profile 116
GLY-145 – Drug Profile 117
GMNL-32 – Drug Profile 118
gpASIT + TM – Drug Profile 119
GSK-2245035 – Drug Profile 121
HP-3060 – Drug Profile 123
Lactococcus lactis G121 – Drug Profile 124
levocabastine hydrochloride – Drug Profile 125
MAM-06301 – Drug Profile 126
MK-8237 – Drug Profile 127
NKTR-125 – Drug Profile 128
NPB-3 – Drug Profile 129
OC-2417 – Drug Profile 130
OC-459 – Drug Profile 131
Olea Europaea Pollen Extract – Drug Profile 133
ONO-4053 – Drug Profile 134
PF-06444752 – Drug Profile 135
PF-06444753 – Drug Profile 136
rBet v1 – Drug Profile 137
rE58 – Drug Profile 139
RT-001 – Drug Profile 140
S-524101 – Drug Profile 142
S-555739 – Drug Profile 144
Small Molecule for Allergic Rhinitis – Drug Profile 145
Small Molecule to Antagonize G Protein Coupled Receptors for Respiratory Disorders – Drug Profile 146
Small Molecules to Inhibit Histamine H3 Receptor for Nasal Congestion and Allergic Rhinitis – Drug Profile 147
Small Molecules to Inhibit PGD2 Synthase for Asthma and Allergic Rhinitis – Drug Profile 148
Small Molecules to Inhibit Spleen Tyrosine Kinase for Allergic Inflammatory Disorders – Drug Profile 149
SUN-0597 – Drug Profile 150
SUNL-731 – Drug Profile 152
TBS-6 – Drug Profile 153
Vaccine for Allergic Rhinitis and Allergic Asthama – Drug Profile 154
VAK-694 – Drug Profile 155
VTX-1463 – Drug Profile 157
VTX-378 – Drug Profile 158
WF-10 – Drug Profile 159
WF-10 liposomal – Drug Profile 161
XmAb-7195 – Drug Profile 162
ZPL-868087 – Drug Profile 163
Allergic Rhinitis – Recent Pipeline Updates 164
Allergic Rhinitis – Dormant Projects 176
Allergic Rhinitis – Discontinued Products 183
Allergic Rhinitis – Product Development Milestones 185
Featured News & Press Releases 185
Appendix 192
Methodology 192
Coverage 192
Secondary Research 192
Primary Research 192
Expert Panel Validation 192
Contact Us 193
Disclaimer 193